Infinity Pharmaceuticals | INFI - Ebitda





Ebitda Veränderung Datum
AbbVie USD 5.37B 1.85B 2025-12
Alterity Therapeutics Limited AUD -7.72M 2.99M 2023-06
Amgen USD 5.14B 775M 2025-12
AstraZeneca USD 5.67B 1.29B 2026-03
Bristol-Myers Squibb USD 2.88B 1.36B 2025-12
Cipla INR 12.55B 6.4B 2025-12
Clal Biotechnology ILS -5.3M 2.09M 2022-12
Compugen USD -7.89M 536K 2025-09
CSL USD 3.13B 1.17B 2025-12
Eisai JPY 30.1B 6.62B 2025-12
Eli Lilly USD 12.14B 4.26B 2025-12
Gilead Sciences USD 3.02B 1.01B 2025-12
GlaxoSmithKline GBP 2.77B 1.65B 2026-03
Grifols EUR 482.04M 7.04M 2025-09
Incyte USD 367.97M 46.53M 2026-03
Infinity Pharmaceuticals USD -10.01M 1.39M 2023-06
Ionis Pharmaceuticals USD -200.02M 42.89M 2025-12
J&J USD 7.19B 2.32B 2025-12
Novartis USD 5.3B 530M 2026-03
Pfizer USD 5.99B 5.23B 2026-03
Plus Therapeutics USD -4.4M 2.94M 2025-09
Roche Holding CHF 12.68B 2.36B 2024-06
TG Therapeutics USD 51.69M 19M 2025-12